aerobactin has been researched along with trimethoprim, sulfadoxine drug combination in 1 studies
| Studies (aerobactin) | Trials (aerobactin) | Recent Studies (post-2010) (aerobactin) | Studies (trimethoprim, sulfadoxine drug combination) | Trials (trimethoprim, sulfadoxine drug combination) | Recent Studies (post-2010) (trimethoprim, sulfadoxine drug combination) |
|---|---|---|---|---|---|
| 269 | 0 | 43 | 40 | 5 | 30 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heilberg, IP; Medina-Pestana, JO; Rocha, LA; Siliano, PR | 1 |
1 other study(ies) available for aerobactin and trimethoprim, sulfadoxine drug combination
| Article | Year |
|---|---|
The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.
Topics: Adhesins, Escherichia coli; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Brazil; Chi-Square Distribution; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fimbriae Proteins; Humans; Hydroxamic Acids; Kidney Transplantation; Logistic Models; Male; Middle Aged; Odds Ratio; Porins; Prospective Studies; Pyelonephritis; Risk Assessment; Risk Factors; Sex Factors; Sulfadoxine; Trimethoprim; Virulence; Virulence Factors; Young Adult | 2010 |